Pelizzari, Giacomo http://orcid.org/0000-0003-1224-9906
Cortiula, Francesco
Giavarra, Marco
Bartoletti, Michele
Lisanti, Camilla
Buoro, Vanessa
Cattaneo, Monica
Rossetto, Ciro
Rizzato, Simona
Puglisi, Fabio
Macerelli, Marianna
Fasola, Gianpiero
Follador, Alessandro
Article History
First Online: 17 July 2020
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this article.
: AF declares honoraria for advisory boards from Astrazeneca and MSD, and reports travel expenses from Roche, MSD, and Eisai. FP declares honoraria for advisory boards, activities as a speaker, and travel expenses from Amgen, Astrazeneca, Celgene, Eisai, Eli Lilly, Ipsen, MSD, Novartis, Pierre-Fabre, Pfizer, Roche, and Takeda, and reports research funding from Astrazeneca, Roche, and Eisai. GP, FC, MG, MB, CL, VB, MC, CR, SR, MM, and GF declare that they have no conflicts of interest that might be relevant to the contents of this article.
: The study was approved by the Internal Review Board of the Department of Oncology, University Hospital of Udine, and by the regional ethics committee (<i>N</i>° Protocol 22,651, ratified in September 2017).
: Informed consent was obtained for the use of clinical data, rendered anonymous, for purposes of clinical research, epidemiology, training, and study of diseases.